To evaluate safety and efficacy of Aragwadhpatra Taila in Dadrukushtha(Tinea Corporis)

Phase 2/3

Not yet recruiting

• Conditions: Tinea corporis. Ayurveda Condition: DADRU-KUSHTHAH,

• Registration Number: CTRI/2023/08/057025
• Lead Sponsor: Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Center Ashta

Brief Summary

Skin conditions pose a significant threat to the person’s well-being, mental health, ability to function, and social participation. In recent years, there has been a considerable increase in the incidence of skin problems in India due to changing lifestyles and food habits. Dadru is one of the most common skin diseases affecting all the ages of population. It is presented with symptoms like Raga(skin discoloration), Pidaka (skin eruptions), Kandu (itching at the site of the lesion), and Mandala udgama  (elevated circular lesion). Many formulations are mentioned in Ayurveda classics for the treatment of Dadru. Here, a study will be done to evaluate the efficacy of Aragwadhpatra Taila in the management of Dadrukushtha. Aragwadhpatra lepa along with kanji is described in granthas for the treatment of Dadrukushta. Aragwadhpatra taila will be prepared by using sharshap taila as base. The drug Aragwadh have kushthghna property. Sharshap taila have katu rasa, ushna virya and katu vipaka and is vata-kapha shamak in nature.It also has kandughna property. Hence to obtain best and beneficial outcome study trial of Aragwadhpatra Taila has been planned to carry.

Study time - 21 days

Follow up- on 7th 14th and 21st day

Drug dose- For local application as per requirement

Study duration- 1 year 6 months

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-08-25
• Study Start: 2023-10-09

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• 1.Age Group between 16 to 60 years.
• 2.Patients having area of skin involvement less than 50%.
• 3.Patient having chronicity less than 1 year.

Exclusion Criteria

• 1.Pregnant women and lactating women.
• 2.Patients having severe systemic disorders.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in Signs & Symptoms of disease like kandu, raga, pidika, mandala after 21 days	7th,14th,21st Day

Secondary Outcome Measures

Name	Time	Method
Improvement in Dermatology Life Quality Index(DLQI)	7th,14th,21st Day

Trial Locations

Locations (1)

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Center Ashta; 🇮🇳 Sangli, MAHARASHTRA, India

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Center Ashta

🇮🇳Sangli, MAHARASHTRA, India

Sakina Maziburrahaman Khan

Principal investigator

9503238769

sakinakhan78692@gmail.com